News
TCBP
0.6620
+2.03%
0.0132
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 1d ago
TC Biopharm awarded funding of $250,000 from G-Rex Grant Program
TipRanks · 5d ago
TCBP Awarded Non-Dilutive Funding Of of $250,000 From The ScaleReady's G-Rex Grant Program
Benzinga · 5d ago
Weekly Report: what happened at TCBP last week (1104-1108)?
Weekly Report · 6d ago
Weekly Report: what happened at TCBP last week (1028-1101)?
Weekly Report · 11/04 10:33
Why LENZ Therapeutics Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Benzinga · 10/28 10:32
Weekly Report: what happened at TCBP last week (1021-1025)?
Weekly Report · 10/28 10:27
TC BioPharm Refutes Rumors Of Delisting From Nasdaq, Confirms Compliance With Nasdaq Requirements
NASDAQ · 10/25 15:48
TC Biopharm refutes social media claim, remains compliant with Nasdaq rules
TipRanks · 10/25 13:50
TCBP Refutes A False Claim Made Earlier This Week On Social Media, Stating There Is Absolutely No Way The Company Is In Any Danger Of Being Delisted From The Nasdaq Stock Exchange
Benzinga · 10/25 13:46
TCBP Enters Research Planning Collaboration With Dr. Carlos Maluquer de Motes For The Development Of A Treatment For Mpox
Benzinga · 10/22 12:38
TC Biopharm enters research pact with Dr. Carlos Maluquer de Motes
TipRanks · 10/22 12:35
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Benzinga · 10/22 12:07
Why iRhythm Technologies Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Benzinga · 10/22 11:06
TC Biopharm (Holdings) PLC – ADR trading halted, volatility trading pause
TipRanks · 10/21 18:23
TC Biopharm (Holdings) PLC – ADR trading resumes
TipRanks · 10/21 18:23
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 10/21 16:31
Weekly Report: what happened at TCBP last week (1014-1018)?
Weekly Report · 10/21 10:25
Weekly Report: what happened at TCBP last week (1007-1011)?
Weekly Report · 10/14 10:43
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga · 10/07 16:31
More
Webull provides a variety of real-time TCBP stock news. You can receive the latest news about TC BioPharm (Holdings) Ltd through multiple platforms. This information may help you make smarter investment decisions.
About TCBP
TC BioPharm (Holdings) plc, formerly TC BioPharm (Holdings) Limited, is a clinical-stage biopharmaceutical company. The Company is focused on developing immunotherapy products that are based on its allogeneic gamma delta T (GD-T) cell platform. Harnessing the innate ability of GD-Ts, the Company has developed a range of clinical-stage cell therapies designed to combat identified cancers and viral infections. In addition to unmodified allogenic GD-Ts for treatment of blood cancers, it is also developing a range of genetically modified chimeric antigen receptor modified T cell (CAR-T) products for treatment of solid cancers. The Company’s pipeline includes OmnImmune, ImmuniStim, TCB009, and TCB005/TCB006. OmnImmune is an allogeneic unmodified GD-T (GD-T2) cell product, used for the treatment of Acute Myeloid Leukaemia (AML). ImmuniStim is used for the treatment of coronavirus disease (COVID-19). TCB009 is developing GD-T2 based cell therapies.